Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
One big number does the work. The ad frames $1,068 as what a $99-a-month offer can really charge, which matches the copy's complaint about up-front annual payments, and that number is surprising enough to stop a scroll. Then the small white card gives Eden's answer: the same $99, charged monthly. It reads like a warning from someone on your side, and it targets a specific frustration rather than just being cheaper. Eden ran several versions of this creative from September 7, 2026.
The ad doesn't explain where $1,068 comes from, and the supporting text under it is too small to read at feed size. A viewer who doesn't already know about annual prepay may not connect the number to the $99 claim above it. Add one readable line under $1,068 that says how it's charged (all at once, upfront) so the math is obvious. The landing page's lifetime price guarantee would also make a strong closing line, since the ad is already about billing surprises.
It sets up the claim the viewer has seen elsewhere, so the next number reads as the reveal.
A big, unexpected number stops the scroll and stands for the upfront charge.
It answers the reveal with Eden's billing terms, so the contrast is about how you pay as well as how much.
$99 a month charged monthly, framed against a $1,068 charge the ad links to other providers' $99-a-month claims.
The ad sends people to Eden's GLP-1 affiliate page, a focused landing page whose hero promises one clear, all-inclusive price with no annual or long-term plans required. That line answers this ad's complaint almost word for word. Prices for both medications sit right above the Start my free assessment button, and the plan inclusions section further down spells out what the monthly price includes. For a billing-surprise ad, it's a tight match.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.